News

Global Health EDCTP3 - 2026 Work Programme out now

Published on | 2 months ago

Programmes
Health

The Global Health EDCTP3 Joint Undertaking has published its Work Programme 2026, announcing €147 million to fund research and innovation projects tackling major global health challenges.

The 2026 calls for proposals will open mid-January 2026 and include six topics:

  • four research and innovation action (RIA) topics (two-stage) aimed at developing new or improved TB drugs, supporting the prevention and management of lower respiratory tract infections, ensuring better prevention, treatment and management of HIV and its co-infections and co-morbidities, and addressing the global challenge of climate and health. Deadline for short proposals is 4 March 2026 (first stage). Succesful consortia at the first stage will be invited to submit a full proposal by 17 September 2026 (second stage).

  • two coordination and support action (CSA) call topics (single-stage) will support training and capacity-building activities in the areas of ethics, regulatory and pharmacovigilance, and enhance integrated research and healthcare through digital innovation and artificial intelligence. Deadline for submission is 31 August 2026.


More information on the Global Health EDCTP3 website. An online Info Day will take place on 5 February 2026. 

The Global Health EDCTP3 Joint Undertaking (GH EDCTP3 JU) is a partnership between the European Union and the European and Developing Countries Clinical Trials Partnership (EDCTP) Association whose members are several EU Member States and Associated countries and several African countries.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1806 articles available search in articles 

Testimonial

Lorcenis - Long Lasting Reinforced Concrete for Energy Infrastructures under Severe Operating Conditions

ChemStream is an innovative chemical R&D company, specialized in translating material problems in sustainable formulations with focus on nano-dispersions, functional coatings and inkjet inks. Within LORCENIS they will develop super absorbing polymers (SAPs) to be mixed within the concrete matrices for improving the active internal curing, self-healing and self-sealing properties of the concrete. Grindig SAPs.

ChemStream bvba and Ghent University are involved in Horizon 2020-project for developing long lasting reinforced concrete for energy infrastructures.